Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Feiglin

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
NPJ Genomic Medicine|February 26, 2024
DNA and RNA base editors can correct the majority of pathogenic single nucleotide variantsAriel Dadush, Rona Merdler-Rabinowicz, David Gorelik, et al.
Journal of Biomedical Informatics|August 14, 2016
A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel diseaseJudith Somekh, Mor Peleg, Alal Eran, et al.
Nature Communications|October 18, 2017
A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cellsYoav Elkis, Moshe Cohen, Etai Yaffe, et al.
Human Molecular Genetics|September 14, 2019
Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndromeSmita Jagtap, Jessica M Thanos, Ting Fu, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Genomics, Proteomics & Bioinformatics|July 20, 2021
CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq AnalysisXintao Qiu, Avery S Feit, Ariel Feiglin, et al.
Journal of Child Neurology|April 22, 2015
CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 GeneGali Heimer, Yair Sadaka, Lori Israelian, et al.
Cancer Cell|February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating MutationsRinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast CancerCristina Guarducci, Agostina Nardone, Douglas Russo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
NPJ Genomic Medicine|February 26, 2024
DNA and RNA base editors can correct the majority of pathogenic single nucleotide variantsAriel Dadush, Rona Merdler-Rabinowicz, David Gorelik, et al.
Journal of Biomedical Informatics|August 14, 2016
A model-driven methodology for exploring complex disease comorbidities applied to autism spectrum disorder and inflammatory bowel diseaseJudith Somekh, Mor Peleg, Alal Eran, et al.
Nature Communications|October 18, 2017
A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cellsYoav Elkis, Moshe Cohen, Etai Yaffe, et al.
Human Molecular Genetics|September 14, 2019
Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndromeSmita Jagtap, Jessica M Thanos, Ting Fu, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Genomics, Proteomics & Bioinformatics|July 20, 2021
CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-seq AnalysisXintao Qiu, Avery S Feit, Ariel Feiglin, et al.
Journal of Child Neurology|April 22, 2015
CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: A Third Allelic Disorder of the ATP1A3 GeneGali Heimer, Yair Sadaka, Lori Israelian, et al.
Cancer Cell|February 14, 2018
Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating MutationsRinath Jeselsohn, Johann S Bergholz, Matthew Pun, et al.
Cancer Research|August 11, 2022
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast CancerAgostina Nardone, Xintao Qiu, Sandor Spisak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast CancerCristina Guarducci, Agostina Nardone, Douglas Russo, et al.
Pageof 3